GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 24.15
+0.89 (3.83%)
At close: Jul 31, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 9.88 billion as of July 31, 2026. Its market cap has increased by 50.11% in one year.
Market Cap
9.88B
Enterprise Value
9.05B
Revenue
830.61M
Ranking
n/a
PE Ratio
60.25
Stock Price
24.15
ChartMarket Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 9.88B, an increase of 30.21%. That is a compound annual growth rate of 6.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 9.88B | 56.83% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 10.68B |
| HitGen | 10.54B |
| Hualan Biological Vaccine | 10.34B |
| Pacific Shuanglin Bio-pharmacy | 9.70B |
| Shanghai Medicilon | 9.41B |
| Nanjing Vazyme Biotech | 9.38B |
| Jiangxi Fushine Pharmaceutical | 9.14B |
| Beijing Hotgen Biotech | 9.07B |